What you are looking at in the image above bears a strong resemblance to spaghetti. That’s because it is spaghetti – but unlike any spaghetti ever made before.At just 372 nanometers across – around 200 times thinner than a human hair – these are the thinnest spaghetti strands the world has seen, some 1,000 times thinner than the famous, 440,000 nanometer-wide su filindeu of Sardinia.
Article contentSYDNEY Breton Books is once again donating $1,000 worth of sales from its 11th annual Cape Breton’s Christmas collection.Article contentThe book, edited and compiled by Ron Caplan, features stories from Cape Breton’s about Christmases past.Through the summer, Caplan approached people randomly to ask if they had a Christmas story to share.Those who did were asked to write it down and submit it for the 11th edition of Cape Breton’s Christmas.Article contentThere are 50 stories in this year’s collection including the tale of the girl who was trapped under a Christmas tree and the story of a hitchhike home for the holidays.As in past years, proceeds from sales of the book are being donated to help make the Christmas season brighter for people in need.“People see this as a win-win-win project, said Caplan in a press release.It gets people writing, it saves hundreds of stories we rarely share, and it continues to make a substantial donation to Feed Nova Scotia.The launch of this year’s Cape Breton Christmas is Dec. 3 at the McConnell Library in Sydney at 6 p.m.Cape Bretons Christmas is available in stores around Cape Breton and across Canada and sells for $21.95.It canShare this article in your social network
HAVANA TIMES – Here are the top international news stories compiled by Democracy Now on Wednesday, December 4, 2024. South Korean Opposition Plans to Impeach President Yoon After Failed Martial Law Declaration Dec 04, 2024 Members of South Korea’s opposition have moved to impeach President Yoon Suk Yeol after he plunged South Korea into crisis by declaring…
Targeting specific strains of the bacteria E.coli with vaccines or other treatments could help reduce the risk of bowel, bladder and prostate cancers, according to scientists.It comes as a study suggested higher cases of certain cancers in industrialised countries such as the UK could be linked to two particular types of E.coli, which can cause infections in the urinary tract and bloodstream.These strains produce a DNA-damaging chemical called colibactin that has been linked to bowel cancer.Working to eradicate them “could offer huge public health benefits”, researchers said, including reducing the need for antibiotics to treat the infections they cause, as well as potentially lowering cancer risk.E.coli is a diverse group of bacteria that are normally harmless and live in the intestines of humans and animals.For the study, published in Lancet Microbe, researchers used genomic surveillance to track different strains across different countries, including the UK, Norway, Pakistan and Bangladesh.The two strains academics focused on are more common in industrialised countries, and cause infections of the bloodstream and urinary tract, rather than food poisoning.These countries also have higher levels of bowel, bladder and prostate cancers, according to researchers.Meanwhile, the team’s analysis showed the strains were much rarer in countries such as Bangladesh and Pakistan, where cases of bowel, bladder and prostate cancers are also lower.Senior author Professor Jukka Corander, of the Wellcome Sanger Institute, University of Oslo, and the University of Helsinki, said: “We have been using large-scale genomics to track E.coli strains across multiple countries for the last five years, using data that goes back to the early 2000s.“This has allowed us to start to see the possible connections between two E.coli strains and cancer incidence rates.”First author Dr Tommi Maklin, of the University of Helsinki and the Wellcome Sanger Institute, added: “E.coli can be found around the world, in many different forms, and understanding how strains of this bacteria impact humans differently can give us a more complete picture of health and disease.“Having access to global genomic data on which strains are found in an area can uncover new trends and possibilities, such as strains in industrialised countries potentially being linked to the risk of certain cancers.“We also need to keep ensuring that countries and regions around the world are included in genomic surveillance research so that everyone benefits from new discoveries.”Prof Corander said he hopes the findings unlock a way of potentially eradicating E.coli which produce colibactin.“Science is not a stand-alone endeavour and by working together with cancer and microbiome experts, we are hopeful that in the future this work might lead to new ways to eradicate colibactin-producing E.coli strains,” he said.“Vaccines or other interventions that target these E.coli strains could offer huge public health benefits, such as reducing the burden of infections and lessening the need for antibiotics to treat these, as well as reducing the risk of cancers that could be linked to the effects of colibactin exposure.”Dr Trevor Lawley, of the Wellcome Sanger Institute, said: “In the future, it could be possible to develop therapeutic probiotics that help to displace unwanted bacterial strains, such as the ones that release colibactin.“Understanding more about the interactions between E.coli and cancer risk highlights the impact our microbiome has on our health and is a crucial avenue to explore if we want to work with our bodies to help combat certain conditions.”
Targeting specific strains of the bacteria E.coli with vaccines or other treatments could help reduce the risk of bowel, bladder and prostate cancers, according to scientists.It comes as a study suggested higher cases of certain cancers in industrialised countries such as the UK could be linked to two particular types of E.coli, which can cause infections in the urinary tract and bloodstream.These strains produce a DNA-damaging chemical called colibactin that has been linked to bowel cancer.Working to eradicate them “could offer huge public health benefits”, researchers said, including reducing the need for antibiotics to treat the infections they cause, as well as potentially lowering cancer risk.E.coli is a diverse group of bacteria that are normally harmless and live in the intestines of humans and animals.For the study, published in Lancet Microbe, researchers used genomic surveillance to track different strains across different countries, including the UK, Norway, Pakistan and Bangladesh.The two strains academics focused on are more common in industrialised countries, and cause infections of the bloodstream and urinary tract, rather than food poisoning.These countries also have higher levels of bowel, bladder and prostate cancers, according to researchers.Meanwhile, the team’s analysis showed the strains were much rarer in countries such as Bangladesh and Pakistan, where cases of bowel, bladder and prostate cancers are also lower.Senior author Professor Jukka Corander, of the Wellcome Sanger Institute, University of Oslo, and the University of Helsinki, said: “We have been using large-scale genomics to track E.coli strains across multiple countries for the last five years, using data that goes back to the early 2000s.“This has allowed us to start to see the possible connections between two E.coli strains and cancer incidence rates.”First author Dr Tommi Maklin, of the University of Helsinki and the Wellcome Sanger Institute, added: “E.coli can be found around the world, in many different forms, and understanding how strains of this bacteria impact humans differently can give us a more complete picture of health and disease.“Having access to global genomic data on which strains are found in an area can uncover new trends and possibilities, such as strains in industrialised countries potentially being linked to the risk of certain cancers.“We also need to keep ensuring that countries and regions around the world are included in genomic surveillance research so that everyone benefits from new discoveries.”Prof Corander said he hopes the findings unlock a way of potentially eradicating E.coli which produce colibactin.“Science is not a stand-alone endeavour and by working together with cancer and microbiome experts, we are hopeful that in the future this work might lead to new ways to eradicate colibactin-producing E.coli strains,” he said.“Vaccines or other interventions that target these E.coli strains could offer huge public health benefits, such as reducing the burden of infections and lessening the need for antibiotics to treat these, as well as reducing the risk of cancers that could be linked to the effects of colibactin exposure.”Dr Trevor Lawley, of the Wellcome Sanger Institute, said: “In the future, it could be possible to develop therapeutic probiotics that help to displace unwanted bacterial strains, such as the ones that release colibactin.“Understanding more about the interactions between E.coli and cancer risk highlights the impact our microbiome has on our health and is a crucial avenue to explore if we want to work with our bodies to help combat certain conditions.”
BBCMonths have passed since the kilts were packed away and the hangovers cured, yet the echoes of Scotland’s summer of fun in Germany continue to resonate.
BBCMonths have passed since the kilts were packed away and the hangovers cured, yet the echoes of Scotland’s summer of fun in Germany continue to resonate.
BayState Business Brokers Reviews and Complaints Analysis Released by IRAEmpire.com – Business News Today – EIN Presswire
Global Alternative Tourism Market Set For 3.9% Growth, Reaching $110.37 Billion By 2028 – Travel Industry Today – EIN Presswire
Global Alternative Tourism Market Set For 3.9% Growth, Reaching $110.37 Billion By 2028 – Travel Industry Today – EIN Presswire